Atorvastatin for preventing the progression of sepsis to severe sepsis (ASEPSIS Trial): a randomised, double-blind, placebo-controlled trial (ISRCTN64637517)

por Patel, JM, Snaith, C, Thickett, D, Linhortova, L, Melody, T, Hawkey, P, Barnett, T, Jones, A, Hong, T, Perkins, G, Cooke, M, Gao-Smith, F
Publicado 2011